Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease 1.

Slides:



Advertisements
Similar presentations
By: Minhazur Sarker Mentor: Dr. Manoj Pastey
Advertisements

Emerging patterns of drug resistance and viral tropism in cART-naïve and failing patients infected with HIV-1 subtype C Thumbi Ndung’u, BVM, PhD Associate.
Designing and Optimizing an Adenovirus Encoded VLP Vaccine against HIV Anne-Marie Andersson PhD Student, University of Copenhagen.
VIRAL VECTORS IN GENE THERAPY Gene Therapy The introduction of nucleic acids into cells for the purpose of altering the course of medical condition or.
Clinical Group n Biology of HIV infection n by Duangrat Inthorn n Mechanism of Reverse Transcriptase Inhibitors and Protease Inhibitors n by Tawitch Suriyo.
The Progression of Liver Fibrosis is Associated with the Severity of the HIV Disease in HIV-HCV Co-infected Female Patients Mohammad K. Mohammad 1, Babu.
Fig 1: HIV-1/HCV and HIV-1/HBV Co-Infection/Co- Culture Systems Philippe A. Gallay 1, Udayan Chatterji 1, Michael Bobardt 1, Daren Ure 2, Dan Trepanier.
RETROVIRUSES.
HIV and AIDS Retrovirus -> Primate Lentivirus Group.
Virus-Cell Interactions
HIV Structure, Lifecycle, and Replication
Viruses that Use Reverse Transcriptase during Replication The retroviruses have an RNA genome that is converted to DNA by RT after infection. The hepadnaviruses.
Viruses and Cancer.
Viruses and Cancer BTY328: Virology
Host-Pathogen Strategies #1
Oncogenic viruses DNA viruses Herpesviridae Papovaviridae
Trends in Biotechnology TB 14 Microinjection, stem cell transfer, gene targeting, and use of retroviruses 1.
Introduction Hepatitis C Virus
1 MicroRNA Silencing of Tumor Suppressor DLC-1 Promotes Efficient Hepatitis C Virus Replication in Primary Human Hepatocytes 指導老師:鄭伯智老師、林宏榮老師 學生:林怡君 (N99H0005)
THE IMMUNOPATHOGENESIS OF HIV INFECTION. THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) 10359bp DNA gp120 gp41 CD4 binding Membrane fusion.
Viral Tissue Reservoirs Are Determined Early and Little Viral RNA Is Detected during Suppression in the Macaque Model Zandrea Ambrose, Ph.D. Division of.
Specific Immune System
Immunodeficiency syndromes. Classification Primary:rare,B,T & combined B &T deficits Secondary: in severe infection, immunosupression(CT,RT),malnutrition,DM,renal.
A new molecular mechanism for HIV-1 latency HIV latency in primary T cells: natural activation/purging by DCs Ben Berkhout Academic Medical Center University.
HIV & AIDS in the United States AIDS deaths in the U.S. decreased by 42% from >1,000,000 Men, Women & Children were living with HIV in 2004.
Quantitative 3D Video Microscopy of HIV Transfer Across T Cell Virological Synapses Anna Buch Wolfgang Hübner et al., Science, 2009.
When I write a manuscript (MS), I start with the results with figures and tables, materials and methods, introduction or discussion, and the abstract.
The mechanism of HCV extrahepatic infection
HIV molecular biology BTY328: Virology
1 Molecular Mechanisms for gp160-Enhanced Apoptosis Keith J. Micoli, Olga A. Mamaeva, George Pan, Eric Hunter and Jay M. McDonald University of Alabama.
HUMAN IMMUNODEFICENCY VIRUS (HIV). INTRODUCTION HIV VIRUS IS HUMAN IMMUNODEFICENCY VIRUS IT CAUSES (ACQUIRED IMMUNODEFICENCY SYNDROME)(AIDS) HIV VIRUS.
Pathway of NF-kB Activation
Acquired Immunodeficiency Syndrome AIDS
HIV genome map This genetic map of the HIV-1 viral genome depicts the
HIV pathogenesis The course of HIV infection 1. Acute Phase 2. Intermediate (asymptomatic) phase -viral load stabilizes at a “set point”. 3. Late (symptomatic)
Retrovirus. Retroviridae –Retrovirus HTLV (human T-cell lymphotropic virus) –Lentivirus HIV.
Cigarette Smoke Extract Suppresses Human Dendritic Cell Function Leading to Preferential Induction of Th-2 Priming 高丰光 Robert Vassallo The Journal of Immunology,
THE IMMUNE RESPONSES TO VIRUSES
HUMAN IMMUNODEFICIENCY VIRUS AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
Interferons Induction of synthesis Induction of antiviral activity Antiviral activities induced by interferons  and  Antiviral activities induced by.
Source: A DULTS AND C HILDREN L IVING WITH HIV/AIDS (Est. Dec 2007) deaths: 2,900,000 in ,100,000 in 2007 new cases: 2,500,000 in.
NIDA Center Genomics Projects Kathie Walters October 2008.
Retroviruses and AIDS 2.
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
The E2DISP Antigen Display System: A Novel HIV Vaccine Approach
Host – hepatitis C viral interactions: The role of genetics
Immune Receptors and Signal Transduction
Immunodeficiency (2 of 2)
Immunological memory Topics Immune regulation  T cells
A typical enveloped virus
Coinfection With HIV-1 and HCV—A One-Two Punch
The Aging Liver in the Aging HIV and HCV Patients
Evaluation of the Patient With HCV Infection
INTRODUCTION TO MEDICAL VIROLOGY Asist.Prof.Baydaa Hameed
Is Hepatitis C Virus Carcinogenic?
Mechanisms of HBV-related hepatocarcinogenesis
Recent Developments in Retroviral-Mediated Gene Transduction
Immunodeficiency (2 of 2)
Hepatitis C virus–cell interactions and their role in pathogenesis
Coinfection With HIV-1 and HCV—A One-Two Punch
Volume 134, Issue 4, Pages (August 2008)
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
Live and Let Die Immunity
Volume 8, Issue 1, Pages (July 2010)
Host – hepatitis C viral interactions: The role of genetics
Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease
Recent Developments in Retroviral-Mediated Gene Transduction
Presentation transcript:

Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease 1

HIV-1/HCV co-infection * Shared routes of infection: - sexual contact - blood stream - IDU * Common with ~ 30% of all HIV-1-infected persons 2

- two-fold acceleration of fibrosis - five-fold higher risk of cirrhosis-related liver complications, etc. Co-infection has profound, adverse consequences. - elevate HCV viral load. - expedite HCV-mediated liver disease progression. Cirrhosis and end-stage liver disease – 50% of all deaths in co-infected patients - leading cause of morbidity and mortality in Western countries. 3

Genomic and virion structure of HIV-1 callutheran.edu Structural: Gag, Pol, and Env Regulatory: Early: Tat, Rev, and Nef Late: Vpr, Vpu, Vif 4

Distinct target cells for infection A. HIV-1 T helper cells Monocytes/microphage Dendritic cells, etc CD4 CCR5 CXCR4 B. HCV Hepatocytes LDLR CD81 SR-B1 Claudin-1 Occludin 1. Receptor/co-receptors 2. Fundamentally different life cycles 5

Possible mechanisms 1.Direct infection of HIV-1 into HCV-infected hepatocytes/HSC 2.Indirect effect A. Viral proteins, such as Env, Tat, and Nef B. Dysfunction immune systems by HIV-1 and/or viral proteins 6

Replication of HIV-1 in human hepatocytes 7

Viral protein candidates 1.Env - interact with CXCR4 or CCR5 co-receptor enhance HCV replication in the replicon induce apoptosis 2.Tat - diffusible protein enhance hepatocarcinogenesis in transgenic mice 8

Relevant Nef functions for up-regulation of HCV replication 1.Induces formation of conduits (filopodia) and secretion of exosomes. 2.Regulates the amount of intracellular lipids by modulating expression of lipid molecules. 3.Forms complexes with and thereby activates several cellular kinases, such as the Src family of tyrosine kinases. 4. Alters host immune responses. 9

Exosome-mediated Nef transfer? A. B. Virol. J

Transfer of Nef protein from Jurkat T cells into hepatocytes. 11

Nef is transferred from HIV-1-infected cells to hepatocytes ∆Nef-HIV-1wt-HIV-1 Huh

Biological significance of Nef transfer 1. Up-regulation of HCV replication 2. Generation of ROS 3. Effect on alcohol-mediated up-regulation of HCV replication 4. Others 13

Nef up-regulates HCV subgenomic replicon expression 14

Nef-mediated induction of ROS 15

Effect of Nef on ethanol-mediated up-regulation of HCV replication 16

p53 Summary 17

Acknowledgement Dohun Pyeon, Ph.D. (UCSM) Khalid Timami, Ph.D. Johnny J He, Ph.D Linden Green, Ph.D. (IUSM) Jinfeng Wang, Ph.D. Myeong-Gwi Ryou, Ph.D. Yan Fan Xiaoyu Luo 18

Thank you all! 19